Covid-19 vaccination–related lymphadenopathy: What to be aware of. Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach. Ultrasound features to differentiate COVID-19 vaccine-induced benign adenopathy from breast cancer related malignant adenopathy. The Author(s), under exclusive licence to Springer Nature Switzerland AG.Ĭhung HL, Whitman GJ, Leung JWT, Sun J, Middleton LP, Le-Petross HT. Type and duration of side effects were similar to that reported by the general population in Phase 3 testing trials of the mRNA vaccines.
These data will inform patient education regarding future vaccine doses, including reassurances about which side effects to expect, particularly lymph node swelling which may impact mammograms after vaccination.
The median duration was 1 week or less after all doses. Lymph node swelling occurred most often in the axilla ipsilateral to the vaccine. The most frequent side effects reported were injection site soreness, fatigue, generalized muscle soreness, headache, and chills, with median duration ≤ 48 h. We assessed the frequency and predictors of side effects. In total, 621 patients who received an mRNA vaccine and responded to the survey were included in analysis.
A survey link was sent to 4945 women who received breast cancer treatment and were prospectively screened for breast cancer-related lymphedema. The purpose of this study is to present side effects reported by a cohort of patients treated for breast cancer. Lymph node swelling is a side effect of the mRNA COVID-19 vaccines, a distressing side effect for women treated for breast cancer.
0 kommentar(er)
